Clinical Trial Update: Exogenous Ketone Esters for Drug Resistant Epilepsy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating exogenous ketone esters for drug-resistant epilepsy is currently recruiting at Sohag University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Exogenous ketone esters (ketone ester)

Snippet

Sponsor: Sohag University | Conditions: Drug Resistant Epilepsy | Phase 2, Phase 3 | Status: RECRUITING